169 related articles for article (PubMed ID: 36765520)
21. Overexpressed Fatty Acid Synthase in Gastrointestinal Stromal Tumors: Targeting a Progression-Associated Metabolic Driver Enhances the Antitumor Effect of Imatinib.
Li CF; Fang FM; Chen YY; Liu TT; Chan TC; Yu SC; Chen LT; Huang HY
Clin Cancer Res; 2017 Aug; 23(16):4908-4918. PubMed ID: 28442505
[No Abstract] [Full Text] [Related]
22. Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer.
Sun X; Hou W; Liu X; Chai J; Guo H; Yu J
Cancer Cell Int; 2020 Dec; 20(1):580. PubMed ID: 33292253
[TBL] [Abstract][Full Text] [Related]
23. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
24. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
Novoa Díaz MB; Carriere P; Gigola G; Zwenger AO; Calvo N; Gentili C
World J Gastroenterol; 2022 Jul; 28(26):3177-3200. PubMed ID: 36051345
[TBL] [Abstract][Full Text] [Related]
25. Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway.
Lu C; Zhang C
Clin Transl Oncol; 2023 Jan; 25(1):160-172. PubMed ID: 36129606
[TBL] [Abstract][Full Text] [Related]
26. The Pharmacological or Genetic Blockade of Endogenous
Grunt TW; Lemberger L; Colomer R; López Rodríguez ML; Wagner R
Front Oncol; 2021; 11():610885. PubMed ID: 33928023
[TBL] [Abstract][Full Text] [Related]
27. Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism.
Shueng PW; Chan HW; Lin WC; Kuo DY; Chuang HY
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742944
[TBL] [Abstract][Full Text] [Related]
28. Intense endoplasmic reticulum stress (ERS) / IRE1α enhanced Oxaliplatin efficacy by decreased ABCC10 in colorectal cancer cells.
Liu X; Wu B; Chen H; Sun H; Guo X; Sun T; Zhou D; Yang S
BMC Cancer; 2022 Dec; 22(1):1369. PubMed ID: 36585626
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
Lupu R; Menendez JA
Curr Pharm Biotechnol; 2006 Dec; 7(6):483-93. PubMed ID: 17168665
[TBL] [Abstract][Full Text] [Related]
30. MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression.
Duan J; Chen L; Zhou M; Zhang J; Sun L; Huang N; Bin J; Liao Y; Liao W
Oncol Rep; 2017 May; 37(5):2583-2592. PubMed ID: 28339092
[TBL] [Abstract][Full Text] [Related]
31. The fatty acid synthase inhibitor orlistat reduces the growth and metastasis of orthotopic tongue oral squamous cell carcinomas.
Agostini M; Almeida LY; Bastos DC; Ortega RM; Moreira FS; Seguin F; Zecchin KG; Raposo HF; Oliveira HC; Amoêdo ND; Salo T; Coletta RD; Graner E
Mol Cancer Ther; 2014 Mar; 13(3):585-95. PubMed ID: 24362464
[TBL] [Abstract][Full Text] [Related]
32. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer.
Zhang B; Chan SH; Liu XQ; Shi YY; Dong ZX; Shao XR; Zheng LY; Mai ZY; Fang TL; Deng LZ; Zhou DS; Chen SN; Li M; Zhang XD
J Cell Mol Med; 2021 Sep; 25(18):8836-8849. PubMed ID: 34378321
[TBL] [Abstract][Full Text] [Related]
33. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
[TBL] [Abstract][Full Text] [Related]
34. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
[TBL] [Abstract][Full Text] [Related]
35. A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction.
Liu H; Liu Y; Zhang JT
Mol Cancer Ther; 2008 Feb; 7(2):263-70. PubMed ID: 18281512
[TBL] [Abstract][Full Text] [Related]
36. Diet-induced alteration of fatty acid synthase in prostate cancer progression.
Huang M; Koizumi A; Narita S; Inoue T; Tsuchiya N; Nakanishi H; Numakura K; Tsuruta H; Saito M; Satoh S; Nanjo H; Sasaki T; Habuchi T
Oncogenesis; 2016 Feb; 5(2):e195. PubMed ID: 26878389
[TBL] [Abstract][Full Text] [Related]
37. The "HER2-PI3K/Akt-FASN Axis" regulated malignant phenotype of colorectal cancer cells.
Li N; Bu X; Wu P; Wu P; Huang P
Lipids; 2012 Apr; 47(4):403-11. PubMed ID: 22218925
[TBL] [Abstract][Full Text] [Related]
38. Study on the mechanism of action of effective monomeric, berberine of Xianglian Pill in inhibiting human colon cancer cells based on fatty acid synthase target.
Li SY; Li Y; Wu ZH; Zhou ZJ; Li CY; Wu TT; Fu SJ; Wang ZY; Zhong ZX; Zhong Y
J Tradit Complement Med; 2023 Nov; 13(6):538-549. PubMed ID: 38020547
[TBL] [Abstract][Full Text] [Related]
39. Isolinderalactone sensitizes oxaliplatin-resistance colorectal cancer cells through JNK/p38 MAPK signaling pathways.
Kwak AW; Park JW; Lee SO; Lee JY; Seo JH; Yoon G; Lee MH; Choi JS; Shim JH
Phytomedicine; 2022 Oct; 105():154383. PubMed ID: 35987016
[TBL] [Abstract][Full Text] [Related]
40. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer.
Shang C; Li Y; He T; Liao Y; Du Q; Wang P; Qiao J; Guo H
J Adv Res; 2022 Mar; 37():169-184. PubMed ID: 35499057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
